Editors Association

Home / Editors Association

About United Scientific Group Editors Association

The scientific industry involved in networking, organizing meetings and publishing scholarly journals is increasing constantly in order to meet the ever changing demands of emerging new concepts and subjects in different fields of science. Rigorous and meticulous policies and guidelines are essential to maintain the highest standards of scientific excellence. United Scientific Group (USG) is fortunate to have a United Scientific Group Editors Association (USGEA) that serves this role. USGEA is an association of United Scientific Group Journals editors with diverse backgrounds and professional experience, who seek to foster cooperation and communication among editors, improve editorial standards, promotes the concept of self-criticism, self-regulation in scholarly publishing, and encourage research on the editorial principles and practices of publishing.

USGEA purpose is to serve the scientific community upholding standards of peer review, editorial independence and other editorial policies.

Main objectives

Create journals having a clear mission and well developed publishing policies.
Abide the industry standards and follow the trends in the rapidly-changing environment of scientific publishing.
Develop challenging themes and to organize customized scientific events.


Provide strategic direction to the publishing house, overseeing activities and progress.
Focused inputs in developing peer review guidelines and editorial policy statements.
Address the significant issues arise from the in-house editors, reviewers, authors and readers.
Resolve the professional problems related to scientific meetings and forums.

Kenneth Blum
Founding President

Kenneth Blum, PhD, DHL

Dr. Kenneth Blum, B.Sc. (Pharmacy), M.Sc., PhD, DHL- received his PhD in Neuropharmacology from New York Medical College and is a graduate from Columbia University and New Jersey College of Medicine. He trained at the Institute of Behavioral Genetics, Colorado University at Boulder, Colorado. He also received a doctor of humane letters from St Martins University. He has published over 500 abstracts, peer– reviewed articles and books (16). He has been the recipient of many grants and awards including a Life-Time Achievement in Addiction Medicine (Holistic Institute on Addiction Studies); Marquis Who Who’s Life –Time Achievement Award, and Presidential Award for Scientific Excellence (National Council of Alcohol & Drug Abuse Councilors), Scientific Achievement Award (City of Life Miami) and Best Abstract (2012) Award ASRA (Pain); Path Foundation Lifetime Achievement Award (2014) and Honorary Full Professor (Eötvös Loránd University, Institute of Psychology, Budapest, Hungary) and American Society of Addiction Medicine Millennium Laboratory Award among many others. He coined the term “Reward Deficiency Syndrome “in 1995 now in Microsoft Dictionary, Gates Scientific dictionary and featured in SAGE Encyclopedia of Abnormal Psychology (2017). Currently he serves as Editor-in-chief of Journal of Reward Deficiency Syndrome & Addiction Science (Editor-in-chief), Co-EIC Neuroimaging in Psychiatry & Neurology, and is on the editorial board of 18 other scientific journals.
Sayon Roy
Founding Vice-President

Sayon Roy, PhD, FARVO

Dr. Sayon Roy is a Professor of Medicine and Ophthalmology in Department Ophthalmology, Boston University. He completed his B.S. and M.S. from University of Kalyani, India. He received his PhD from Boston University. Dr. Roy’s seminal work has identified several genes in the retina that are abnormally expressed in diabetic retinopathy. His pioneering work has led to novel gene modulatory techniques in retinal vascular cells using antisense oligonucleotides via intravitreal injection. Dr. Roy has received numerous awards including the American Diabetes Association Research Award for the commitment and dedication towards the fight against diabetes, the 2006 Mentor of the Year Award from Boston University, and the 2008 Innovative Award from the Juvenile Diabetes Research Foundation.